{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:44:54Z","timestamp":1790232294521,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.beem.2026.102101","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:19:31Z","timestamp":1775099971000},"page":"102101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The cross-talk between prolactin and growth hormone in pituitary adenomas"],"prefix":"10.1016","volume":"40","author":[{"given":"Erica A.","family":"Giraldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"McCord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana G.","family":"Ioachimescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.beem.2026.102101_bib1","article-title":"The epidemiology, diagnosis and treatment of prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2026.102101_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S2213-8587(25)00227-X","article-title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","volume":"13","author":"Fleseriu","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2026.102101_bib3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2026.102101_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41574-025-01148-2","article-title":"Consensus on acromegaly therapeutic outcomes: an update","volume":"21","author":"Melmed","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102101_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11102-018-0891-5","article-title":"IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomas","volume":"21","author":"Akirov","year":"2018","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"9","key":"10.1016\/j.beem.2026.102101_bib7","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1210\/jcem.86.9.7819","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eprac.2022.03.013","article-title":"The prolactin per unit tumor volume ratio accurately distinguishes prolactinomas from secondary hyperprolactinemia due to stalk effect","volume":"28","author":"Faje","year":"2022","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.beem.2026.102101_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.14791\/btrt.2025.0028","article-title":"Resolution of hyperprolactinemia caused by pituitary stalk compression after transsphenoidal surgery for pituitary tumors","volume":"13","author":"Oh","year":"2025","journal-title":"Brain Tumor Res Treat"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen.13156","article-title":"The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the prolactin epidemiology, audit and research study (PROLEARS)","volume":"86","author":"Soto-Pedre","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2026.102101_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2017.13705","article-title":"Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults","volume":"318","author":"Li","year":"2017","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.beem.2026.102101_bib12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4158\/EP15938.DSC","article-title":"American association of clinical endocrinologists, American College of Endocrinology Disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia","volume":"21","author":"Samson","year":"2015","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.beem.2026.102101_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.eprac.2024.11.002","article-title":"Clinical features and hormonal profile of macroprolactinomas presenting with the Hook Effect: a systematic review","volume":"31","author":"Mahmoud","year":"2025","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1016\/j.beem.2026.102101_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-025-01134-8","article-title":"Pituitary incidentaloma: a Pituitary Society international consensus guideline statement","volume":"21","author":"Fleseriu","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102101_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2022.101467","article-title":"Biochemical discrepancies in the evaluation of the somatotroph axis: elevated GH or IGF-1 levels do not always diagnose acromegaly","volume":"64","author":"Peixe","year":"2022","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4158\/EP11324.OR","article-title":"Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone","volume":"18","author":"Subbarayan","year":"2012","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2026.102101_bib17","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves F.T., Feibelmann T.C.M., Fernandes M.L.M.P., Discrepancy between IGF-1 and GH during 75 g oral glucose tolerance test measures to acromegaly screening in a patient with macroprolactinoma \u2014 case report and literature review. 2007;51(3):494-499.","DOI":"10.1590\/S0004-27302007000300020"},{"issue":"12","key":"10.1016\/j.beem.2026.102101_bib18","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1651-2227.2005.tb01869.x","article-title":"A case of macroprolactinoma and elevated insulin-like growth factor-I in a young boy","volume":"94","author":"Eyal","year":"2005","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib19","first-page":"1497","article-title":"Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas","volume":"78","author":"Friend","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102101_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological correlations in pituitary adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.beem.2026.102101_bib21","doi-asserted-by":"crossref","DOI":"10.3171\/2010.7.FOCUS10169","article-title":"Growth hormone-secreting adenomas: pathology and cell biology","volume":"29","author":"Lopes","year":"2010","journal-title":"Neurosurg Focus"},{"issue":"1-2","key":"10.1016\/j.beem.2026.102101_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00687965","article-title":"Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy","volume":"71","author":"Felix","year":"1986","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.beem.2026.102101_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","article-title":"GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors","volume":"32","author":"Mete","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.beem.2026.102101_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2015.151","article-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","volume":"29","author":"Mete","year":"2016","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-20-1273","article-title":"Transcription factor immunohistochemistry in the diagnosis of pituitary tumours","volume":"184","author":"Lenders","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102101_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s42000-019-00154-0","article-title":"Acidophil stem cell pituitary adenoma: a case report and literature review","volume":"18","author":"Annapurni","year":"2019","journal-title":"Horm (Athens)"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2008.03514.x","article-title":"Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience","volume":"71","author":"Erickson","year":"2009","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102101_bib28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L","article-title":"Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases","volume":"47","author":"Horvath","year":"1981","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.beem.2026.102101_bib29","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMra2409076","article-title":"Acromegaly","volume":"393","author":"Giustina","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2026.102101_bib30","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/j.wneu.2022.10.043","article-title":"Endoscopic endonasal transsphenoidal surgery for patients with prolactinomas: indications and outcomes","volume":"168","author":"Force","year":"2022","journal-title":"World Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib31","doi-asserted-by":"crossref","first-page":"e1833","DOI":"10.1210\/clinem\/dgae652","article-title":"The changing treatment paradigm for prolactinoma-a prospective series of 100 consecutive neurosurgical cases","volume":"110","author":"van Trigt","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.beem.2026.102101_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073543","article-title":"Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.beem.2026.102101_bib34","doi-asserted-by":"crossref","first-page":"e2178","DOI":"10.1210\/clinem\/dgae126","article-title":"Differences between GH- and PRL-cosecreting and GH-secreting pituitary adenomas: a series of 604 cases","volume":"109","author":"Araujo-Castro","year":"2024","journal-title":"J Clin Endocrinol & Metab"},{"key":"10.1016\/j.beem.2026.102101_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1571598","article-title":"Comparison of the clinical and prognostic characteristics of patients with different pathological types in acromegaly","volume":"16","author":"Chong","year":"2025","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102101_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1530\/EJE-11-1119","article-title":"The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases","volume":"166","author":"Wang","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102101_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12020-019-02029-1","article-title":"Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up","volume":"66","author":"Lv","year":"2019","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s11102-020-01075-7","article-title":"Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly","volume":"23","author":"Varlamov","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12902-021-00850-2","article-title":"Association of different pathologic subtypes of growth hormone producing pituitary adenoma and remission in acromegaly patients: a retrospective cohort study","volume":"21","author":"Dehghani","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3171\/2018.4.JNS18230","article-title":"Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes","volume":"131","author":"Rick","year":"2019","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-025-05041-w","article-title":"Clinical characteristics and pathological features of growth hormone-secreting pituitary adenoma combined with hyperprolactinemia","volume":"174","author":"Mo","year":"2025","journal-title":"J Neurooncol"},{"key":"10.1016\/j.beem.2026.102101_bib42","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/j.wneu.2021.04.003","article-title":"Plurihormonal PIT-1-positive pituitary adenomas: a systematic review and single-center series","volume":"151","author":"Andrews","year":"2021","journal-title":"World Neurosurg"},{"issue":"7","key":"10.1016\/j.beem.2026.102101_bib43","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-25-0020","article-title":"Clinical features of plurihormonal pituitary adenoma subtypes","volume":"32","author":"Turin","year":"2025","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.beem.2026.102101_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/02688697.2020.1713989","article-title":"Patients with true mixed growth hormone and prolactin-secreting pituitary adenoma: a case series of 12 patients","volume":"34","author":"Gulbadin","year":"2020","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.beem.2026.102101_bib45","article-title":"Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients","volume":"12","author":"Guo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.beem.2026.102101_bib46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1055\/a-1207-1132","article-title":"Hyperprolactinemia in acromegaly is related to prolactin secretion by somatolactotroph tumours","volume":"52","author":"Van Laethem","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2026.102101_bib47","article-title":"Clinical and pathological spectrum of acromegaly: distinguishing GH-PitNETs, mammosomatotrophs and mixed tumors","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102101_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s11102-019-00982-8","article-title":"Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients","volume":"22","author":"Pappy","year":"2019","journal-title":"Pituitary"},{"issue":"9","key":"10.1016\/j.beem.2026.102101_bib49","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1210\/jc.2017-00773","article-title":"Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification","volume":"102","author":"Raverot","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102101_bib50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11102-020-01063-x","article-title":"Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review","volume":"23","author":"Agrawal","year":"2020","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2026.102101_bib51","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/02688697.2021.1947977","article-title":"A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission","volume":"38","author":"Unal","year":"2024","journal-title":"Br J Neurosurg"},{"issue":"3","key":"10.1016\/j.beem.2026.102101_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ecl.2020.05.006","article-title":"The role of dopamine agonists in pituitary adenomas","volume":"49","author":"Giraldi","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1016\/j.beem.2026.102101_bib53","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0103","article-title":"Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas","volume":"14","author":"Araujo-Castro","year":"2025","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2026.102101_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvae003","article-title":"Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study","author":"Urwyler","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/jc.2009-1360","article-title":"Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation","volume":"95","author":"Lania","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102101_bib56","first-page":"116","article-title":"Transformation of a microprolactinoma into a mixed growth hormone and prolactin-secreting pituitary adenoma","volume":"2","author":"Dessimoz","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.beem.2026.102101_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12902-024-01622-4","article-title":"Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight","volume":"24","author":"Caprio","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.beem.2026.102101_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2025.101669","article-title":"Dynamic changes in IGF-1 levels during cabergoline therapy in prolactinoma","volume":"82","author":"Demir","year":"2025","journal-title":"Growth Horm IGF Res"},{"issue":"7","key":"10.1016\/j.beem.2026.102101_bib59","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0043","article-title":"Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs","volume":"31","author":"Araujo-Castro","year":"2024","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.beem.2026.102101_bib60","first-page":"724","article-title":"Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage","volume":"79","author":"Greenman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102101_bib61","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/ejendo\/lvae053","article-title":"Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion","volume":"190","author":"Biagetti","year":"2024","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:20:21Z","timestamp":1788866421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1521690X26000229"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102101","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cross-talk between prolactin and growth hormone in pituitary adenomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102101"}}